SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around a token burn event contingent on reaching a specific number of Stocktwits watchers. Discussions highlight the project's strong community, recent gains, and planned airdrop, driving excitement. Some users are drawing comparisons to other Solana-based meme coins and anticipating future utilities.

Aventus

Aventus is trending as traders discuss its potential due to its relatively low market capitalization and limited supply on Coinbase, with some highlighting its strong technology. The community is actively speculating on potential exchange listings and anticipating a significant price pump. Some users are pointing to its blockchain capabilities and partnerships with Polkadot and Vodafone.

Shiba Inu (SHIB) is a meme token which began as a fun currency and has now transformed into a decentralized ecosystem. During the initial launch, 50% of the supply was allocated into Vitalik Buterin's ethereum wallet.   As a result of that, Vitalik proceeded to donate 10% of his SHIB holdings to a COVID-19 relief effort in India and the remaining 40% is burnt forever. That donation was worth about $1 billion at that time, which makes it one of the largest donation ever in the world.  What is the Shiba Inu community working on right now? The Shiba Inu team launched a decentralized exchange called Shibaswap with 2 new tokens, LEASH and BONE. LEASH is a scarce supply token that is used to offer incentives on Shibaswap. BONE is the governance token for holders to vote on proposals on Doggy DAO.

Shiba Inu

Shiba Inu is trending as the community discusses potential catalysts and price movements, with some eyeing other meme coins like $GASH.X for quick gains. Despite mixed sentiment, some SHIB holders remain confident, while others express frustration with the lack of progress and call for more impactful token burning mechanisms. The conversation also includes broader discussion around market trends and the potential for alt season.

What is the project about? Pepe is a community based meme token surround the iconic meme Pepe the frog. Pepe aims to leverage the power of such an iconic meme to become the most memeable memecoin in existence.   What makes your project unique? Pepe is here to make memecoins great again. Ushering in a new paradigm for memecoins, Pepe represents the memecoin in it's purest simplicity. With zero taxes, liquidity locked forever, and contract immutable, Pepe is for the people, forever. Pepe is about culture, rallying together a community to have fun and enjoy memes, fueled purely by memetic power.   History of your project. Pepe was stealth launched on Friday, April 14th, 2023.   What’s next for your project? Pepe will focus on developing a tight-knit community around the token and building resources to enrich the communities knowledge and success in crypto through a token gated group, newsletter, and more tools.   What can your token be used for? Pepe can be used to speculate on the power of memes, and does not pretend to be anything more.

Pepe

PEPE.X is trending as the community discusses potential moves in meme coins and altcoins. Some users are weighing PEPE.X against newer coins, while others are debating whether to buy the dip or take profits. Overall, community sentiment seems mixed.

Robinhood Markets, Inc is a financial services platform, which engages in the provision of retail brokerage and offers trading in U.S. listed stocks and Exchange Traded Funds, related options, and cryptocurrency trading, as well as cash management, which includes debit cards services. The company was founded by Vladimir Tenev and Baiju Prafulkumar Bhatt in 2013 and is headquartered in Menlo Park, CA.

Robinhood Markets Inc - Ordinary Shares - Class A

Robinhood Markets Inc

Robinhood's stock is trending following news of its inclusion in the S&P 500, generating excitement among investors who see it as a sign of legitimacy and long-term potential. The community is buzzing about potential price increases and discussing option strategies to capitalize on the expected volatility, while also reflecting on the company's past controversies.

Memecoin on Injective taken over by the community.

Nonja

$NONJA.X is trending as the community rallies around its strong connection to the Injective ecosystem, anticipating amplified gains as $INJ.X gains traction. The community highlights its unique art, engaged community, and significant portion of its market cap burned to LP as key reasons for its potential. Bullish sentiment is further fueled by discussions around a potential $INJ Staked ETF.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

Infinite Money Glitch ($IMG.X) is trending as community members highlight its Solana ($SOL.X) rewards system for holders, emphasizing its potential for daily passive income and outperforming traditional finance options. The community is rallying around its resilience and recent developments, including a new developer and upcoming partnerships. Discussions focus on $IMG.X's architecture as a rewarding system built to last, contrasting it with fleeting hype-driven tokens.

Kenvue, Inc. is a consumer health company, which engages in manufacturing and selling healthcare products which includes cosmetics, drugs, and medical devices. Its brands include Aveeno, BAND-AID Brand, Johnson’s, Listerine, Neutrogena, and Tylenol. It operates through the following segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment includes cough, cold and allergy, pain care, digestive health, and smoking cessation. The Skin Health and Beauty segment offers face and body care, and others. The Essential Health segment focuses on oral care, baby care, women's health, and wound care. The company was founded on February 23, 2022 and is headquartered in Summit, NJ.

Kenvue Inc

Kenvue ($KVUE) is trending due to concerns over potential links between Tylenol, a key product, and autism, sparked by reports involving RFK Jr. This has triggered a sharp stock decline and increased options activity, with community discussions focusing on the validity of the claims and potential buying opportunities amidst the uncertainty. Some traders are dismissing the concerns as overblown, while others brace for potential lawsuits and further downside.

Jellification is a fun and colorful project built on the Solana blockchain. Each icon shows a unique character or symbol that represents a part of our creative world. The soft, jelly-like design makes the visuals playful and eye-catching. We want to bring a light and friendly feeling to Web3. Every logo is carefully designed to match our smooth and fun style. This project is easy to join and made for everyone. Let’s make crypto more fun together with Jellification!

JELLY

JELLY.X is trending as users discuss its potential, fueled by the founder's background with Venmo and Facebook, and its unique video chat application. Some community members are speculating on potential listings and partnerships, while others express concerns about the project's legitimacy. The conversation is centered on its possible integration with established platforms and predictions of significant market cap growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Conversations around DJT are active, with some discussing Trump's recent statements on vaccines and others debating the stock's valuation relative to other tech companies like META. The community is also focused on the broader political and economic implications of Trump's policies, with both positive and negative viewpoints being expressed. Some are pointing to tariff revenue increases while others express concerns about rising unemployment and the economy.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates

Cue Biopharma (CUE) delivered earnings and revenue surprises of +30.77% and +47.70%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates

YmAbs Therapeutics (YMAB) delivered earnings and revenue surprises of +74.07% and +5.96%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

scPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Lags Revenue Estimates

scPharmaceuticals (SCPH) delivered earnings and revenue surprises of -13.33% and -2.19%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Cue Biopharma, Inc. (CUE) Reports Q1 Loss, Misses Revenue Estimates

Forecasting The Future: 4 Analyst Projections For Cue Biopharma

Latest Ratings for CUE
 DateFirmActionFromTo Nov 2020BerenbergInitiates Coverage OnBuy May 2020StifelMaintainsBuy May 2020OppenheimerMaintainsOutperform
 View More Analyst Ratings for CUE...

Cue Biopharma to Host Business Update Call and Webcast

BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...

Navalign LLC Takes $66,000 Position in Cue Biopharma, Inc. (NASDAQ:CUE)

Navalign LLC bought a new stake in shares of Cue Biopharma, Inc. (NASDAQ:CUE  Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities  Exchange...

Jefferies Financial Group Begins Coverage on Cue Biopharma (NASDAQ:CUE)

Jefferies Financial Group assumed coverage on shares of Cue Biopharma (NASDAQ:CUE  Free Report) in a research report released on Wednesday, MarketBeat reports. The firm issued a buy rating and...

Cue Biopharma presenting data on lead clinical asset CUE-101 at symposium

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Cue Biopharma's Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium

BOSTON, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of therapeutic biologics to selectively modulate...

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a novel and proprietary class of biologic drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its pipeline includes Immuno-oncology, CUE-100 framework, CUE-200 framework, and autoimmune disease. The company was founded by Ronald D. Seidel III, Steven Almo, and Rodolfo Chaparro on December 31, 2014 and is headquartered in Boston, MA.

Current Price	$0.78
Prev Close	$0.785
Open	$0.7851
Dividend Yield	0.00%
50-Day Moving Average	$0.798
Beta	1.36
Avg. Volume	124,447.19
PE Ratio	-1.42

52-Week High	$1.99
52-Week Low	$0.45
Market Capitalization	$60.32M
EPS (Annual)	-$0.7221
Price to Book	3.30
Revenue Per Employee	$226,512.20
Enterprise Value/EBITDA	N/A

CUE
Cue Biopharma Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CUE News

CUE Cue Biopharma Inc